The U.S. Patent and Trademark Office (USPTO) has awarded Cerenion‘s C-Trend technology a patent related to the C-Trend Index algorithm.
The patent is third in the USA and seventh in total. The patent gives strong protection to the C-Trend Index algorithm. The EEG signal is processed by the C-Trend Index algorithm in C-Trend technology to produce the C-Trend Index, which is a single number. The Index is a single value between 0 and 100 that describes the patient’s EEG slow wave activity. Slow wave activity, which takes place during sedation and deep sleep, is crucial for a healthy brain. Cerenion C-Trend technology has been granted patents in the United States, The European Union, Japan, and China and multiple intellectual property applications have been filed worldwide.
Oulu-based Cerenion has developed the world’s ﬁrst practical method for measuring the brain function of intensive care patients. The company’s technology aims to reveal the status of the brain as one simple score – at the bedside and without requiring any changes to the care of the patient. The solution works by combining standard EEG measurement with advanced machine learning algorithms and artificial intelligence.